Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | C5 | P01031 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19445719 | 0.91 | KLKB1 (0.41) | LMNAMEN1KMT2AHSD17B10TSHR | |
| SCHEMBL13815084 | 0.88 | SUV39H2 (0.51) | LMNAMEN1KMT2ASUV39H2AAK1 | |
| SCHEMBL15782431 | 0.87 | LMNA (0.42) | LMNAMEN1KMT2ASMN1; SMN2SUV39H2 | |
| SCHEMBL13815099 | 0.85 | AAK1 (0.48) | LMNAMEN1KMT2ASUV39H2AAK1 | |
| SCHEMBL10199166 | 0.85 | FFAR1 (0.41) | TSHR | |
| SCHEMBL13973873 | 0.84 | LMNA (0.42) | LMNAMEN1KMT2AHSD17B10SMN1; SMN2 | |
| SCHEMBL19445181 | 0.84 | MMP2 (0.42) | LMNAMEN1KMT2AHSD17B10MAPT | |
| SCHEMBL15782432 | 0.83 | LMNA (0.43) | LMNAMEN1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL19445576 | 0.83 | SUV39H2 (0.40) | LMNAMEN1KMT2AHSD17B10SMN1; SMN2 | |
| SCHEMBL10260677 | 0.82 | KLKB1 (0.41) | LMNAMEN1KMT2ATSHRAAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8946475-B2 | Processes for preparing a polymeric compound | CELLCEUTIX CORPORATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-20130274502-A1 | Processes For Preparing A Polymeric Compound | POLYMEDIX, INC. (US) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274502-A1 | Processes For Preparing A Polymeric Compound | F12, ALG1, ABCB11 | LMNA 3036/4885MEN1 445/4885KMT2A 3278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.